Post Knowledge Assessment

Quiz Summary

0 of 17 Questions completed

Questions:

You have already completed the quiz before. Hence you can not start it again.

Quiz is loading…

You must sign in or sign up to start the quiz.

You must first complete the following:

Results

Quiz complete. Results are being recorded.

Results

0 of 17 Questions answered correctly

Average score
Your score

Oops, it appears you didn’t pass. As a reminder, you must score a 70% or better to pass. Let’s try it again.
Wahoo! Way to go! You passed.

Current
Review
Answered
Correct
Incorrect

Question 1 of 17

1. Question
The most effective dietary option in EoE is:
- Elemental formula
- Milk elimination
- Milk, Wheat, Egg, Soy elimination
- Testing based elimination diet
Question 2 of 17

2. Question
Currently approved therapies for EoE include:
- Elemental formula
- Oral budesonide suspension
- Anti-IL-5
- All of the above
- None of the above
Question 3 of 17

3. Question
1. As a favor to your dermatologist colleague, you agree to see a 3 year old female with severe atopic dermatitis. She presents with both parents whom you recognize from late night TV commercials, advertising their services for those seeking legal recourse due to work related injury. They have been busy researching atopic dermatitis on the internet and have found disparate information that has left them frustrated. In addressing their queries, which of the following is the true statement?
- The association of loss-of-function mutations in the gene encoding filaggrin (FLG) with atopic dermatitis is the strongest of the genetic abnormalities identified to date.
- New insights into pathophysiology of atopic dermatitis provide a rationale for a reactive treatment approach.
- A panel of biomarkers unique to atopic dermatitis can define disease severity and reliably measure therapeutic effects.
- Treatment of adults with moderate-to-severe atopic dermatitis with dupilumab resulted in a significant increase in their EASI score.
Question 4 of 17

4. Question
The parents of the child from the Question 3 have some additional questions they would like to address regarding their daughter’s atopic dermatitis. Which of the following is the correct statement?
- Their daughter’s atopic dermatitis is more likely to go into remission due to early age of onset.
- A biopsy of her non-lesional skin would show a normal skin barrier, but some immune abnormalities.
- A biopsy of her non-lesional skin would show an abnormal skin barrier, but no immune abnormalities.
- Treating a flare of her eczema with anti-inflammatory medications would help restore a more diverse skin microbiome.
Question 5 of 17

5. Question
Which of the following is most predictive of an OSA diagnosis?
- Male gender
- Age > 55 years old
- Neck size > 17 inches
- BMI > 30 Kg/m²
Question 6 of 17

6. Question
The factors most predictive of early life sensitization are:
- Bedroom HDM exposure
- Bedroom HDM exposure + pet and rodent exposure
- Bedroom HDM exposure + pet and rodent exposure + microbiome taxa diversity
- All depends on viral infection
Question 7 of 17

7. Question
Factors associated with more severe airflow limitation in adults:
- Low FEV1 at first measurement
- Female gender
- Higher AHR
- Absence of atopy
- All of the above
- Low FEV1 at first measurement + Higher AHR
Question 8 of 17

8. Question
In determining the adverse effects of psychological stress on immune balance, the most fundamental factor appears to be:
- Intensity and duration of the stressor
- Underlying health of the individual
- Genetic predisposition
- Genetic predisposition
- Baseline immune status prior to the stress experience
Question 9 of 17

9. Question
Which statement is correct regarding omalizumab in chronic urticarial?
- Rate of response is equivalent with 150 & 300 mg doses
- Complete responders are similar with 150 & 300 mg doses
- Failures occur in 30-40% of CU patients
- No meta-analysis has proven the efficacy of omalizumab in CU
Question 10 of 17

10. Question
Amongst alternative agents for chronic urticaria, which medication most frequently causes adverse effects leading to discontinuation of the medication?
- Cyclosporine
- Dapsone
- Mycophenolate
- Sulfaslazine
Question 11 of 17

11. Question
Who can report adverse events to VAERS?
- Any healthcare provider who has knowledge of an adverse event
- Doctors
- Patients who are affected by vaccine adverse events
- Anyone
Question 12 of 17

12. Question
It is generally safe to give an egg allergic patient each of the following vaccines, EXCEPT?
- Influenza
- Measles Mumps Rubella
- Hepatitis A
- Yellow Fever
Question 13 of 17

13. Question
Per the NIAID addendum guidelines on peanut allergy prevention, for which of the following infants is early peanut introduction recommended?
- Infants with severe eczema
- Infants with moderate eczema
- Infants with mild eczema
- All of the above
Question 14 of 17

14. Question
Which of the following is NOT true about MACRA & MIPS?
- You will receive an automatic negative adjustment to Medicare payments if you don't participate
- Since I don’t have many Medicare patients, this won’t affect me much
- MACRA shifts financial risk to physicians
- MACRA bases payments more on value and quality – and less on volume
- Participating in an Alternative Payment models may increase your payments
Question 15 of 17

15. Question
Which of the following does NOT characterize SLIT therapy?
- Efficacy in allergic asthma
- Prevention of further sensitization in monosensitized subjects.
- Persisting benefit after discontinuation
- Absence of systemic adverse reactions
- Defined dosing for grass, ragweed and house dust mite tablets.
Question 16 of 17

16. Question
Which of the following in NOT true?
- Clinical improvement with epicutaneous AIT can persist for 2 years without boosting.
- Systemic adverse reactions have been reported with epicutaneous AIT
- The clinical improvement with intralymphatic AIT can persist 3 years without boosting
- There is a slightly increased risk of systemic reactions with intralymphatic AIT compared to standard SCIT.
- Pain with intralymphatic AIT is similar to that with a venipuncture.
Question 17 of 17

17. Question
Best treatment for minor epistaxis in a cardiac patient on clopidogrel bisulfate is:
- Topical decongestant spray
- Saline spray and petroleum jelly
- Cold compress on face, firm pressure nasal bones, lie supine
- Seek immediate care in closest emergency department

Quiz Summary

Information

Results

Results

Categories

1. Question

2. Question

3. Question

4. Question

5. Question

6. Question

7. Question

8. Question

9. Question

10. Question

11. Question

12. Question

13. Question

14. Question

15. Question

16. Question

17. Question